瘤细菌VNP20009表达IFNβ通过重塑瘤微环境来抑制黑色素瘤的进展
Lina Liu1, Qiang Li1, Chen Chen1
1The State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences; Nanjing University, Nanjing 210023, Jiangsu, China.
iScience
|March 21, 2024
概括
这项研究表明,使用瘤向细菌输送干扰素-β (IFNβ) 可以重编程瘤相关性中性粒细胞 (TANs) 来对抗癌症. 这种方法在临床前模型中有效抑制了黑色素瘤的生长和转移.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 微生物学 微生物学
背景情况:
- 与瘤相关的中性粒细胞 (TAN) 具有可塑性,在瘤微环境 (TME) 中表现为亲瘤或反瘤.
- 调节TAN表型为癌症治疗提供了潜在的治疗策略.
研究的目的:
- 为了研究通过细菌介导的干扰素-β (IFNβ) 输送用于改造TAN和抑制黑色素瘤进展的疗效.
- 评估在临床前黑色素瘤模型中以表达IFNβ (VNP-IFNβ) 的方式改造的VNP20009的治疗潜力.
主要方法:
- 使用瘤向细菌VNP20009来提供IFNβ (VNP-IFNβ).
- 在B16F10肺转移和皮下异种移植模型中进行临床前评估.
- 评估免疫细胞透,表型和激活,包括中性粒细胞,巨细胞和树突细胞.
主要成果:
- 在肺转移中,VNP-IFNβ治疗导致了抗瘤原体表型的中性粒细胞和巨细胞的透增加.
- 增强树突细胞和CD4+T细胞介导的抗瘤免疫反应的激活.
- 与对照VNP治疗相比,显著抑制黑色素瘤生长和转移.
结论:
- 通过细菌介导的IFNβ有效地重塑瘤免疫微环境,使其处于抗瘤原生状态.
- VNP-IFNβ证明了抑制黑色素瘤进展和转移的治疗潜力.
- 这一策略通过准免疫细胞可塑性,代表了细菌媒介瘤治疗的进步.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


